The Healthcare business of Thomson Reuters, US, has announced the introduction of MarketScan Treatment Pathways, a secure web-based analytical tool that researchers can use to quickly understand medical care, outcomes and costs for discrete populations of patients.
Treatment Pathways allows researchers to access the MarketScan Research Databases or other large datasets to conduct cross-sectional or longitudinal analyses including descriptive reporting without the need for data intake, software or custom programming. The tool allows users to build a visual pathway of patient treatment over time for a particular disease or condition and analyse patient cohorts at any point in the pathway.
The MarketScan Research Databases contain de-identified healthcare claims data reflecting the real-world clinical care of more than 148 million patients — said to be the largest proprietary dataset of its kind. Academic, industry, and government researchers have reportedly used this information for decades to analyse the efficacy of medical treatments, the cost of care, prescription drug utilisation patterns and other important healthcare issues. It seeks to enable researchers to explore patterns in these databases in new ways.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
